The CRO Leadership Awards recognizes the top performing outsourcing organizations in the drug development arena. For 2021, Quotient Sciences has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards.
For the 2021 CRO Leadership Awards, Clinical Leader and Life Science Leader teamed up with Industry Standard Research (ISR) to determine award recipients. 60 contract research organizations (CROs) were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey. Survey participants were recruited from pharma and biopharma companies of all sizes and were screened for decision-making influence related to working with contract research organizations. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.
The Company received leadership awards in five of the overall six categories. The categories included: Capabilities, Compatibility, Expertise, Reliability, Quality, and Phase IV, each further divided into three groups – Big Pharma, Small Pharma, and Overall. Additionally, champion awards are given to companies that score 11/2 standard deviation more above the weighted average in each of the categories and are deemed “top performers”.
Champion Award Winning Categories:
- Expertise (Overall)
- Quality (Overall)
Leadership Award Winning Categories:
- Capabilities (Overall, Small Pharma)
- Compatibility (Overall, Small Pharma)
- Expertise (Overall, Small Pharma)
- Reliability (Overall, Small Pharma)
- Quality (Overall, Small Pharma)